Imaging of heme/hemeproteins in nucleus of the living cells expressing heme-binding nuclear receptors  by Itoh, Ryuhei et al.
FEBS Letters 587 (2013) 2131–2136journal homepage: www.FEBSLetters .orgImaging of heme/hemeproteins in nucleus of the living cells expressing
heme-binding nuclear receptors0014-5793/$36.00  2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
http://dx.doi.org/10.1016/j.febslet.2013.05.036
Abbreviations: NPAS2, neuronal PAS2; DCFH-DA, 20 ,70-dichlorodihydroﬂuorescin
diacetate; DCFH, dichlorodihydroﬂuorescin; DCF, dichlorodihydroﬂuorescein; ROS,
reactive oxygen species; NLS, nuclear localization signal; FCS, fetal calf serum;
DMEM, Dulbecco’s modiﬁed Eagle’s medium; SDS, sodium dodecylsulfate; PBS,
phosphate-buffered saline; BSA, bovine serum albumin; ALAS1, d-aminolevulinic
acid synthase 1
⇑ Corresponding author. Fax: +81 75 724 7760.
E-mail address: taketani@kit.ac.jp (S. Taketani).Ryuhei Itoh a, Ken-ichi Fujita a, Anfeng Mu a, Dao Hoang Thien Kim a, Tran Tien Tai a, Ikuko Sagami b,
Shigeru Taketani a,c,⇑
aDepartment of Biotechnology, Kyoto Institute of Technology, Kyoto 606-8585, Japan
bGraduate School of Life and Environmental Sciences, Kyoto Prefectural University, Sakyo-ku, Kyoto 606-8522, Japan
c Insect Biomedical Center, Kyoto Institute of Technology, Kyoto 606-8585, Japana r t i c l e i n f o
Article history:
Received 28 March 2013
Revised 30 April 2013
Accepted 9 May 2013
Available online 2 June 2013
Edited by Stuart Ferguson
Keywords:
Hemeprotein
Cytoglobin
Neuronal PAS2
REV-erba
20 ,70-Dichlorodihydroﬂuorescin diacetatea b s t r a c t
Several factors involved in the core circadian rhythm are PAS domain proteins, one of which, neu-
ronal PAS2 (NPAS2), contains a heme-binding motif. It is thought that heme controls the transcrip-
tional activity of core circadian factors BMAL1-NPAS2, and that the heme-binding nuclear receptor
REV-erba negatively regulates the expression of BMAL1. To examine the role of heme in the nucleus,
we expressed nuclear hemeproteins including the nuclear localization signal-added cytoglobin,
NPAS2 and REV-erba. Then, the living cells expressing these proteins were treated with 20,70-dichlo-
rodihydroﬂuorescin diacetate (DCFH-DA). The ﬂuorescent signal derived from DCFH-DA was
observed in the nucleus. When the cells were cultured with hemin, the signal of heme in the nucleus
increased. Considering that DCFH-DA reacted with heme, we propose that the use of DCFH-DA could
be useful in detection of the heme moiety of hemeprotein in vivo.
:Clock and Bmal1 colocalize by ﬂuorescence microscopy (View interaction)
Npas2 and Bmal1 colocalize by ﬂuorescence microscopy (View interaction)
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20,70-Dichlorodihydroﬂuorescin (DCFH) is a ﬂuorogenic probe
that has been widely used in the detection of oxidative stress in
cells. The diacetate ester form of DCFH, 20,70-dichlorodihydroﬂuor-
escin diacetate (DCFH-DA), is relatively resistant to oxidation, but
when taken up by cells, is de-acetylated to form DCFH. The ﬂuores-
cent product of DCFH was shown to be formed as a 2-electron oxi-
dation product, dichlorodihydroﬂuorescein (DCF), in reactive
oxygen species (ROS)-liberated cells [1,2]. The generation of ROS
as well as radical reaction occurs upon injury to various tissues
and red blood cells, and the production of hydroxyl radical from
hydrogen peroxide by the release of heme from hemoglobin and
myoglobin follows cell membrane damage [3]. Both heme and ironcan be involved in the generation of potentially harmful ROS [3].
On the other hand, we found that the ﬂuorescence from DCFH-
DA markedly increased in hemin-treated cells, and occurred inde-
pendently of the generation of ROS [4]. Namely, hemeproteins such
as hemoglobin and cytochrome c are potent catalysts of DCFH
oxidation, and can be detected by the formation of DCF as a
ﬂuorescent compound with the reduction of the oxidized form of
hemeprotein/heme [4,5].
Circadian rhythm is a fundamental regulatory factor for
various aspects of physiological functions including sleep/wake
cycles, blood pressure, temperature and metabolism [6,7]. Cellular
rhythms are controlled and maintained through interconnected
transcriptional feedback of clock genes. The cycle involves two
transcriptional factors, BMAL1 and CLOCK, which heterodimerize
to activate a number of circadian genes [8]. Recently, it was found
that transcriptional factors including neuronal PAS2 (NPAS2_,
REV-erba and Bach1 are capable of binding heme, and control
the heme-dependent transcriptional activity of the corresponding
gene [9–11]. NPAS2, a transcriptional factor homologous to
CLOCK, has been shown to bind heme through the PAS domains
and to function as a gas sensor [12]. In addition, an orphan
nuclear receptor, REV-erba, can bind heme and regulates the
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Fig. 1. Expression of cytoglobin and NLS-cytoglobin in HEK293T cells. (A) Localization of cytoglobin and NLS-cytoglobin in HEK293T cells. HEK293T cells were transfected
with pCG-HA-cytoglobin (Upper panel) and pCG-HA-NLS-cytoglobin (Lower panel) and cultured for 24 h. After the cells were ﬁxed, they were incubated with anti-HA
antibody, followed by incubation with cy2-conjugated anti-mouse Ig. The nuclei of the cells were also stained with propidium iodide (PI). Phase contrast images of the cells
are shown at left side. (B) Microscopic observation of DCF ﬂuorescence in cytoglobin- and NLS-cytoglobin-expressing HEK293T cells. Cells transfected with mock DNA, pCG-
HA-cytoglobin and pCG-HA-NLS-cytoglobin, as above were treated with 10 lM DCFH-DA for 10 min. After the cells were washed with DMEM, they were visualized by
confocal microscopy. White bars: 10 lm. (C) Immunoblot analysis. The nuclear fraction (N) of the transfected and control HEK cells was separated from the cytosolic fraction
(C). Proteins of both fractions were analyzed and immunoblotted using anti-REV-erba, actin (cytosolic marker) and Ki-67 (nuclear marker).
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these transcriptional factors were demonstrated with puriﬁed re-
combinant proteins after they were synthesized in Escherichia coli
[10–12]. None of these factors was shown to utilize a heme moi-
ety in vivo. Owing to the low expression of these nuclear factors
in mammalian cells, it is actually unclear whether the nuclear
receptors function by binding heme in the nucleus of mammalian
cells. As a control with well-characterized hemeprotein, when
cytoglobin fused to nuclear localization signal (NLS) was ex-
pressed in the nucleus, heme moiety of cytoglobin was detected
with DCFH-DA in vivo. Then, to clarify the binding of heme to
the nuclear factors in the nucleus, we overexpressed BMAL1/
NPAS2 complex in the nucleus and found that the nuclear locali-
zation of heme depended on the expression in living cells. Stable
transfectant expressing REV-erba also showed augmentation of
heme signal in the nucleus.
2. Materials and methods
2.1. Materials
DCFH-DA was fromMolecular Probes Co (Eugene, OR). Fetal calf
serum (FCS) and Dulbecco’s modiﬁed Eagle’s medium (DMEM)
medium were from GE Healthcare (Buckinghamshire, UK). Anti-BMAL1 and anti-Rev-erba antibodies were purchased from Santa
Cruz Biotechnology (Santa Cruz, CA). Anti-HA was a product of
Nacalai-Tesque (Kyoto, Japan). Cy2-conjugated anti-goat and
anti-mouse Ig were products of Millipore Co. (Tokyo, Japan). Hemin
was dissolved in dimethyl sulfoxide at a concentration of 20 mM,
then diluted 20-fold with phosphate-buffered saline (PBS) contain-
ing 10 mg/ml bovine serum albumin (BSA). All other chemicals
used were of analytical grade.
2.2. Plasmids
Plasmids pCG-HA-NPAS2 (mouse NPAS2), pcDNA3-BMAL1
(mouse BMAL1), and pCG-HA-CLOCK (mouse CLOCK) were as
described previously [12]. To construct pCG-HA-NLS-cytoglobin,
the NLS fragment (590–732 bp) of PLAGL2 [13] was ampliﬁed by
PCR. Primers 50-AATCTAGAAGGCGGTTCTATACTCG-30 and 50-AATC-
TAGACTGTGAGTGGCTCTTCT-30 were used. Ampliﬁed cDNAs were
digested with XbaI and ligated into XbaI-digested pCG-HA-cytoglo-
bin [14]. To obtain the full-length cDNA fragment of human
REV-erba, PCR reaction was performed with the following primers:
50-AAAAGCTTACGACCCCTGGACTCCAA-3 and 50-AATCTAGAT-
CACTGGGCGTCCACCC-30 for REV-erba and human kidney cDNA li-
brary as a template. Then, to make mammalian expression vector
carrying REV-erba, the ampliﬁed cDNA was digested with
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Fig. 2. Nuclear localization of BMAL1/CLOCK and BMAL1/NPAS2 in HEK 293T cells. HEK293T cells were co-transfected with pcDNA3-BMAL1 and pCG-HA-CLOCK or pcDNA3-
BMAL1 and pCG-HA-NPAS2, and cultured for 24 h. After the cells were ﬁxed, they were incubated with anti-HA, followed by incubation with cy2-conjugated anti-mouse Ig.
PI: propidium iodide staining. White bars: 10 lm.
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(Life Technologies, Carlsbad, CA).
2.3. Cell culture
HeLa cells and HEK293T cells were maintained in DMEM
supplemented with 10% FCS, 50 U/ml penicillin, and 50 lg/ml
streptomycin. The cells were transfected with pCG-HA-cytoglobin
[14], pCG-HA-NLS-cytoglobin, pCG-HA-NPAS2, pCG-HA-CLOCK or
pCDNA3-BMAL1 by the lipofection method [13] and cultured for
24 h. To obtain HeLa cells constitutively expressing REV-erba,
pEF-REV-erba (5.0 lg) was transfected with calcium phosphate,
as described previously [15]. For selection, G418 (Wako Chemicals,
Tokyo, Japan) at a ﬁnal concentration of 300 lg/ml was added to
the culture medium. After 5 days, colonies of the G418-resistant
cells were trypsinized, seeded in a 24-well tissue culture plate
and cultured in medium containing G418 (300 lg/ml). Individual
clones were isolated and examined for the expression of human
REV-erba by immunoblotting, using anti-REV-erba antibodies.
Three REV-erba-expressing clones were obtained, mixed to avoid
clonal variation and maintained in DMEM containing 7% FCS and
antibiotics. The cells were treated for 16 h in the medium supple-
mented with 7% FCS containing 20 lM hemin.
2.4. Microscopy
The cells in 3.5 cm dishes were washed with PBS (+) (PBS
containing 1 mM CaCl2 and 0.5 mM MgCl2), ﬁxed with 4% parafor-
maldehyde for 20 min, and permeabilized in 0.1% TritonX-100 withPBS (+) for 1 h. After blocking with 2% FCS in PBS (+), incubation
with the primary antibodies was carried out, followed by incuba-
tion with a ﬂuorolink Cy2-conjugated rabbit anti-mouse Ig
[13,15]. The localization of the antigens in the cells was visualized
using a Zeiss confocal microscope or a Nikon ﬂuorescence micro-
scope Model ECLIPSE E600 (Tokyo, Japan) [13]. To obtain the image
of heme in cells, living cells were treated with 10 lM DCFH-DA for
10 min, washed three times with PBS, and the localization of
ﬂuorescence in the cells was examined by confocal microscopy.
2.5. Immunoblotting
The cellular proteins were separated by sodium dodecylsulfate
(SDS)–polyacrylamide gel electrophoresis and transferred onto a
polyvinylidene diﬂuoride membrane (Bio-Rad Laboratories, Hercu-
les, CA). Immunoblotting was carried out with antibodies for HA,
REV-erba and actin, as the primary antibodies [14,15]. The nuclear
fraction of HEK cells was separated from the cytosolic fraction, as
described previously [16].
2.6. Fluorescence spectrophotometry
Cells suspended in PBS were lysed by sonication. The lysates
were then treated with 10 lM DCFH-DA at 37 C. The aliquots of
the sample were withdrawn and the DCF ﬂuorescence was mea-
sured using spectroﬂuorometer with excitation at 500 nm and
emission by scanning from 510 to 550 nm [4,5]. The content of
heme in cells was determined by ﬂuorescence spectrophotometry
after the conversion of heme to protoporphyrin [4,16].
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Fig. 3. DCF ﬂuorescence in BMAL1/CLOCK- and BMAL1/NPAS2-expressing HEK293T
cells. The cells expressing BMAL1/CLOCK and BMAL1/NPAS2 were cultured without
or with 20 lM hemin for 16 h. The cells were then treated with 10 lM DCFH-DA for
10 min. After washing the cells, they were then visualized by confocal microscopy.
White bars: 10 lm.
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3.1. Expression of cytoglobin in cytosol and nucleus
Cytoglobin is known to be a cytosolic hemeprotein [14]. To
examine the localization of cytoglobin, pCG-HA-cytoglobin was
transfected into HEK293T cells and cultured for 16 h. Indirect
immunoﬂuorescence microscopy with the transfected HEK cells
revealed that the staining of HA-cytoglobin occurred in the cytosol
(Fig. 1A). To evaluate cytoglobin/heme in cells, the living cells tran-
siently expressing cytoglobin were treated with 10 lM DCFH-DA
for 10 min. The DCF-ﬂuorescence was mainly found in the cytosol
(Fig. 1B). Then, the NLS of a nuclear protein, PLAGL2 [13], was fused
to the N-terminal of cytoglobin and the resulting NLS-cytoglobin
was expressed in HEK cells. Immunoﬂuorescence with anti-HA
antibody revealed that NLS-cytoglobin had become localized in
the nucleus. Immunoblots analysis conﬁrmed the localization of
cytoglobin (26 kDa) in the cytosol and NLS-cytoglobin (29 kDa) in
the nucleus (Fig. 1C). The treatment of living cells expressing
NLS-cytoglobin with DCFH-DA resulted in a strong ﬂuorescent sig-
nal in the nucleus. When the cells were ﬁxed, the intensity of DCF
ﬂuorescence in the cells diminished. These results indicated that
DCFH-DA could detect NLS-cytoglobin/heme expressed in the nu-
clei of living cells.
3.2. The detection of heme-binding nuclear factors by DCFH-DA
NPAS2 is known to be a heme-binding rhythmic factor that
forms a complex with BMAL1 in the nucleus [9,12]. Plasmids carry-
ing HA-tagged NPAS2 and BMAL1 were co-transfected into HEK
cells, and the cellular localization of BMAL1/NPAS2 was examined
with anti-BMAL1 and -HA. As shown in Fig. 2, BMAL1 and HA-tagNPAS2 were found in the nucleus. Then, we examined the localiza-
tion of heme in the BMAL1/NPAS2-transiently expressing cells. The
ﬂuorescence derived from DCFH was predominantly found in the
nuclei of living cells (Fig. 3), suggesting that NPAS2 expressed in
the nucleus can bind heme. As a control experiment, we expressed
CLOCK, which is another partner of BMAL1 and was recently found
to bind heme in vitro, although there has been no information on
the function of its heme binding [17]. When the BMAL1/CLOCK
complex was expressed in the nucleus and heme staining with
DCFH-DA was examined in living cells, no clear localization of
heme was found in these cells (Fig. 3). When the cells expressing
BMAL1/NPAS2 were treated with 20 lM hemin, intense DCFH-de-
rived ﬂuorescence in the nucleus was found, while the ﬂuorescence
of cells expressing CLOCK with hemin was weakly observed in
whole cells (Fig. 3B). REV-erba is also reported to be a heme-bind-
ing nuclear receptor [10]. We generated HeLa cells stably express-
ing human REV-erba. Immunoblot analysis showed the expression
of REV-erba with a mass of 80 kDa in REV-erba transfectant
(Fig. 4A). The expression of REV-erba in the nucleus was observed
by indirect immunoﬂuorescence study with anti-REV-erba
(Fig. 4B). Microscopic observations revealed that REV-erba was
localized in the nucleus, where most cells were stained by DCFH-
DA (Fig. 4C). The incubation of these cells with 20 lM hemin led
to an increase in the intensity of the ﬂuorescence in the nucleus.
These results indicate that the DCF ﬂuorescence reﬂected heme
binding to REV-erba in the nucleus.
4. Discussion
The present study ﬁrst demonstrated the imaging of heme in
the nucleus of hemeprotein-expressing cells. DCFH has proved to
be a good marker for measuring hemeproteins as well as ROS. In
a model experiment, we generated cytoglobin fused to NLS, and
the resulting NLS-cytoglobin was expressed in the nucleus
(Fig. 1). The heme binding of NLS-cytoglobin in the nuclei of living
cells was observed by a strong ﬂuorescent signal from DCFH-DA.
We [5] previously found that hemeproteins including hemoglobin,
myoglobin and lactoperoxidase were detected by the formation of
DCF as a ﬂuorescent compound with the reduction of the oxidized
form of hemeprotein/heme. Consistent with the observations that
an increase in the DCF ﬂuorescence with cell lysates of the cells
expressing cytoglobin and NLS-cytoglobin was more than that of
control cells (Fig. S1) and that the level of intracellular heme in
cytoglobin-expressing cells was more than that in control cells
(Fig. S2), DCFH-DA can be oxidized by heme/hemeprotein. How-
ever, the mechanism involved in the heme-dependent ﬂuorescence
from DCFH-DA remains unexplored. Hemeproteins, NPAS2 and
REV-erba, present in the nucleus bound heme, a ﬁnding similar
to that for cells containing a large amount of myeloperoxidase
and hemoglobin [18,19]. When the cells expressing NPAS2 or
REV-erba were cultured in the presence of hemin, the intensity
of the DCF ﬂuorescence in the nucleus increased (Figs. 3 and 4).
Thus, the microscopic observation by imaging the DCFH-derived
ﬂuorescence is a sensitive method to estimate the intracellular le-
vel and localization of hemeproteins of cells. From these observa-
tions, it is also implied that native NPAS2 and REV-erba bind
heme in the nucleus, which regulates their transcriptional
activities.
Because nuclear receptors including NPAS2 and REV-erba have
been shown to bind heme in vitro [10,11,20], a question arose of
whether heme binding to these factors is biologically relevant. Fur-
thermore, recent studies showed the heme binding of various pro-
teins with no known role for such binding [17,21–23]. Heme is
hydrophobic and is known to aggregate in aqueous solution and
to require detergents to maintain monodispersity. It should be
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Fig. 4. Nuclear localization of REV-erba and heme in REV-erba-stably-expressing HeLa cells. (A) Immunoblot analysis. Cellular proteins in REV-erba-stably-expressing and
control HeLa cells were analyzed. Immunoblotting was performed with REV-erba and anti-actin. (B) Indirect immunoﬂuorescence of REV-erba. REV-erba-expressing
transfectant and control cells were ﬁxed, and were immunostained with anti-REV-erba. Phase contrast images of the cells are shown at left side. PI: propidium iodide
staining. (C) Heme imaging of REV-erba. The cells were cultured without or with 20 lM hemin for 16 h. The DCF ﬂuorescence of living transfectant and control cells was
observed with DCFH-DA. White bars: 10 lm.
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risk of artiﬁcial binding when heme binding is examined with puri-
ﬁed proteins [24]. To overcome these obstacles, direct evidence of
heme binding to these proteins in vivo is needed. The expressed
NPAS2 and REV-erba were shown to bind heme, and exogenously
added hemin can be utilized as a heme moiety of nuclear heme-
binding factors in mammlian cells (Figs. 3 and 4C). The heme moi-
ety of CLOCK was not found in BMAL1/CLOCK-expressing cells. The
reason for the discrepancy in the results of heme binding of CLOCK
between the present ﬁndings and a previous study [17] is un-
known, but it may be explained by the difference between
in vitro and in vivo observations. We have now shown that the
treatment of cells with DCFH-DA leads to the generation of the
ﬂuorescence with heme/hemin, and microscopic examination with
living cells revealed the localization of heme/hemeprotein in vivo.
d-Aminolevulinic acid synthase 1 (ALAS1), a rate-limiting en-
zyme of heme biosynthesis, is under the circadian control and is
regulated by clock transcription factors, NPAS2 and the co-activa-
tor PGC-1a [9]. NPAS2 suppresses heme biosynthesis by lowering
the transcription of ALAS1 gene since the heme-dependent repres-
sion of ALAS1 was attenuated in the liver of NPAS2-mutated mice
[11]. On the other hand, REV-erba suppresses the biosynthesis of
its ligand, heme, by the down-regulation of PGC-1a [25]. Con-
versely, lowering of the intracellular level of heme reduced the
suppressive function of REV-erba, and enhanced the PGC-1a-
dependent stimulation of the transcription of ALAS1 [25]. How-
ever, the precise mechanisms involved in the suppression of ALAS1
expression by heme have yet to be established. On the basis of thepresent observations that heme reacted with DCFH in the nucleus,
it is possible that change in the activity of nuclear heme-binding
factors by heme leads to suppression of the expression of the
ALAS1 gene via REV-erba. Considering that sensing of the redox
state of heme and gases including O2, CO and NO by nuclear recep-
tors basically controls the functions of their activities [9,26], more
detailed studies on the movement of nuclear heme are required for
clariﬁcation of regulation of gene expression in terms associated
with the circadian rhythm.
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